Lundbeck
HLUN-B.CO
#2803
Rank
HK$47.71 B
Marketcap
HK$48.09
Share price
-2.55%
Change (1 day)
13.57%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Earnings for Lundbeck (HLUN-B.CO)

Earnings in 2025 (TTM): HK$5.98 Billion

According to Lundbeck's latest financial reports the company's current earnings are HK$3.80 Billion. , an increase over its 2024 earnings that were of HK$4.32 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lundbeck from 2009 to 2025

Annual earnings

Year Earnings Change
2025 HK$5.99 B38.47%
2024 HK$4.32 B25.74%
2023 HK$3.44 B21.77%
2022 HK$2.82 B31.57%
2021 HK$2.14 B-4.61%
2020 HK$2.25 B-45.06%
2019 HK$4.10 B-34.04%
2018 HK$6.21 B12.83%
2017 HK$5.51 B93.99%
2016 HK$2.84 B-137.28%
2015 -HK$7.63 Billion-1246.24%
2014 HK$0.66 B-72.36%
2013 HK$2.40 B4.38%
2012 HK$2.30 B-55.18%
2011 HK$5.14 B5.65%
2010 HK$4.86 B-5.9%
2009 HK$5.17 B